Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Current Taxes (2021 - 2022)

Arcus Biosciences has reported Current Taxes over the past 2 years, most recently at $18000.0 for Q3 2022.

  • Quarterly results put Current Taxes at $18000.0 for Q3 2022, changed N/A from a year ago — trailing twelve months through Sep 2022 was $18000.0 (changed N/A YoY), and the annual figure for FY2021 was $2.0 million, changed.
  • Current Taxes for Q3 2022 was $18000.0 at Arcus Biosciences, roughly flat from $18000.0 in the prior quarter.
  • Over the last five years, Current Taxes for RCUS hit a ceiling of $2.8 million in Q1 2022 and a floor of $18000.0 in Q2 2022.